0 likes | 11 Views
The global rheumatic myocarditis treatment market is estimated to garner a robust CAGR of 5% over the forecast period, i.e., 2023u20132035. The market is segmented on the basis of diagnosis into echocardiogram, electrocardiogram, and others, out of which, the echocardiogram segment is estimated to gain a notable share over the forecast period, owing to the accurate and detailed image produced by using ultrasound waves.
E N D